吉林敖東(000623.SZ):以1億元對金海發藥業增資 用於“現代中藥智能化生產線建設項目”建設等
格隆匯4月16日丨吉林敖東(000623.SZ)公佈,吉林敖東集團金海發藥業股份有限公司(“金海發藥業”)系公司控股子公司,該公司註冊資本為1.41億元,公司直接持有1.3996億股,佔該公司總股本的99.26%,公司子公司吉林敖東延邊藥業股份有限公司持有104萬股,佔該公司總股本的0.74%,公司對該公司的表決權比例為100%。
公司以自有資金1億元對金海發藥業增資,增資價格按照淨資產值0.9796元/股,以滿足金海發藥業的發展規劃。
此次增資完成後,金海發藥業註冊資本變更為243,082,483元(具體金額以工商登記為準),公司將直接持有金海發藥業242,042,483股,佔該公司總股本99.57%,公司子公司吉林敖東延邊藥業股份有限公司持有104萬股,佔該公司總股本的0.43%,公司對該公司表決權比例仍為100%。
公司以自有資金對金海發藥業進行增資,主要用於“現代中藥智能化生產線建設項目”建設及滿足金海發藥業未來的業務需要。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.